Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727438 | SCV000535897 | likely benign | not provided | 2020-06-05 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727438 | SCV000708540 | uncertain significance | not provided | 2017-05-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080209 | SCV000756163 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329000 | SCV002627202 | likely benign | Cardiovascular phenotype | 2020-02-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001080209 | SCV001453453 | likely benign | Alstrom syndrome | 2020-01-01 | no assertion criteria provided | clinical testing |